Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayato Yokota

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Pharmaceutical Health Care and Sciences|March 14, 2025
Effect of isavuconazole on the concentration of tacrolimus in a patient with genotype CYP3A5*1/*3: a case reportHayato Yokota, Yumiko Akamine, Harumi Hatakeyama, et al.
Journal of Pharmaceutical Health Care and Sciences|June 26, 2024
Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancerHayato Yokota, Ruriko Asahi, Yumiko Akamine, et al.
Biomedicines|September 28, 2023
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and SafetyTatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa, et al.
Investigational New Drugs|May 22, 2020
ABCG2 C421A polymorphisms affect exposure of the epidermal growth factor receptor inhibitor gefitinibSho Sakamoto, Kazuhiro Sato, Yuri Takita, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Pharmaceutical Health Care and Sciences|March 14, 2025
Effect of isavuconazole on the concentration of tacrolimus in a patient with genotype CYP3A5*1/*3: a case reportHayato Yokota, Yumiko Akamine, Harumi Hatakeyama, et al.
Journal of Pharmaceutical Health Care and Sciences|June 26, 2024
Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancerHayato Yokota, Ruriko Asahi, Yumiko Akamine, et al.
Biomedicines|September 28, 2023
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and SafetyTatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa, et al.
Investigational New Drugs|May 22, 2020
ABCG2 C421A polymorphisms affect exposure of the epidermal growth factor receptor inhibitor gefitinibSho Sakamoto, Kazuhiro Sato, Yuri Takita, et al.
Pageof 2